Sponsored Symposia: Molecular-level insights in Kidney & Pancreas Care: Prospera Deep-Dive Sponsored by Natera
March 25, 2021 01:00pm EDT
Originally presented at the AST Cutting Edge of Transplantation (CEoT) Meeting in February 2021, this rebroadcasted session explores the new applications of cell-free and genomic DNA in kidney and pancreas transplant care management. Transplant physicians will share new Natera data and their experiences incorporating Prospera into their routine care protocols. Specifically, early promising Prospera use in kidney and pancreas patients will be highlighted. Furthermore, recent experiences in using genetic testing for waitlisted patients will be discussed.
Learning Objectives:
- Hear how your transplant colleagues are incorporating Prospera into their routine care protocols.
- Preview early data on the use of donor-derived cell-free DNA in canse and kidney-pancreas recipients for rejection surveillance
- Learn how to refind diagnosis of kidney disease for recipients on the transplant waitlist
This is not an official function of the CEoT Meeting and is not endorsed by the AST.
Video will be posted on the AST's Youtube Channel, be sure to subscribe to watch at your convenience.
